SARS in the intensive care unit

Current Infectious Disease Reports

Volumn 6, Issue 3, 2004, Pages 228-233

  Joynt, Gavin M ^a   Yap, H Y ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; DIURETIC AGENT; HYPERTENSIVE FACTOR; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; PURINE NUCLEOSIDE DERIVATIVE; RIBAVIRIN; STEROID;

AGE; AIRBORNE INFECTION; ARTIFICIAL VENTILATION; BAROTRAUMA; BONE NECROSIS; COMORBIDITY; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LACTATE DEHYDROGENASE BLOOD LEVEL; MORBIDITY; MORTALITY; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS TRANSMISSION;

EID: 3142623029     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-004-0013-6     Document Type: Review

References (51)

1. Fouchier RA, Kuiken T, Schutten M, et al.: Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003, 423:240.
2. World Health Organization: Summary table of SARS cases by country, 1 November 2002-7 August 2003. http://www.who.int/csr/sars/country/table2003_09_23/en/. Accessed January 8, 2004.
3. Cluster of severe acute respiratory syndrome cases among protected health-care workers - Toronto, Canada, April 2003. Morb Mortal Wkly Rep 2003, 52:433-436.
4. Fowler RA, Lapinsky SE, Hallett D, et al.: Critically ill patients with severe acute respiratory syndrome. JAMA 2003, 290:367-373.
5. Lew TW, Kwek TK, Tai D, et al.: Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003, 290:374-380.
6. Booth CM, Matukas LM, Tomlinson GA, et al.: Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003, 289:2801-2809.
7. Lee N, Hui D, Wu A, et al.: A major outbreak of severe acute respiratory syndrome in Hong Kong. N Eng J Med 2003, 348:1986-1994.
8. Peiris JS, Chu CM, Cheng VC, et al.: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003, 361:1767-1772.
9. Choi KW, Chau TN, Tsang O, et al.: Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 2003, 139:715-723.
10. Peiris JS, Yuen KY, Osterhaus AD, Stohr K: The severe acute respiratory syndrome. N Engl J Med 2003, 349:2431-2441.
11. Gomersall CD, Joynt GM, Lam P, et al.: Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med 2004, 30:381-387.
12. Bernard GR, Artigas A, Brigham KL, et al.: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
13. Tsui PT, Kwok ML, Yuen H, Lai ST: Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003, 9:1064-1069.
14. Nicholls JM, Poon LL, Lee KC, et al.: Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003, 361:1773-1778.
15. Ning Q, Brown D, Parodo J, et al.: Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 1998, 160:3487-3493.
16. Chu CM, Cheng VC, Hung IF, et al.: The role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004, 59:252-256.
17. Hsu LY, Lee CC, Green JA, et al.: Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis 2003, 9:713-717.
18. Chan KS, Lai ST, Chu CM: Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 2003, 9:399-406.
19. Zhao Z, Zhang F, Xu M, et al.: Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003, 52:715-720.
20. So LK, Lau AC, Yam LY, et al.: Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003, 361:1615-1617.
21. Ho JC, Ooi GC, Mok TY, et al.: High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 200, 168:1449-1456.
22. Sung JJY, Wu A, Joynt GM, et al.: Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 2004, In press.
23. Thompson BT: Glucocorticoids and acute lung injury. Crit Care Med 2003, 31:S253-S257.
24. Meduri GU, Headley AS, Golden E, et al.: Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280:159-165.
25. Brun-Buisson C, Brochard L: Corticosteroid therapy in acute respiratory distress syndrome: better late than never? JAMA 1998, 280:182-183.
26. Antonio GE, Wong KT, Chu WC, et al.: Imaging in severe acute respiratory syndrome (SARS). Clin Radiol 2003, 58:825-832.
27. Cordingley JJ, Keogh BF: The pulmonary physician in critical care: ventilatory management of ALI/ARDS. Thorax 2002, 8:729-734.
28. Gattinoni L, Chiumello D, Russo R: Reduced tidal volumes and lung protective ventilatory strategies: where do we go from here? Curr Opin Crit Care 2002, 8:45-50.
29. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. New Engl J Med 2000, 342:1301-1308.
30. Eichacker PQ, Gerstenberger EP, Banks SM, et al.: Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002, 166:1510-1514.
31. Ward NS: Effects of prone position ventilation in ARDS. An evidence-based review of the literature. Crit Care Clin 2002, 18:35-44.
32. Gattinoni L, Tognoni G, Pesenti A, et al.: Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001, 345:568-573.
33. Pelosi P, Gattinoni L: Acute respiratory distress syndrome of pulmonary and extra-pulmonary origin: fancy or reality? Intensive Care Med 2001, 27:457-460.
34. Gattinoni L, Pelosi P, Suter PM, et al.: Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am J Respir Crit Care Med 1998, 158:3-11.
35. Lim CM, Kim EK, Lee JS, et al.: Comparison of the response to the prone position between pulmonary and extrapulmonary acute respiratory distress syndrome. Intensive Care Med 2001, 27:477-485.
36. Dellinger RP, Zimmerman JL, Taylor RW, et al.: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998, 26:15-23.
37. Humphrey H, Ball J, Sznajder I, et al.: Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990, 97:1176-1180.
38. Mitchell JP, Schuller D, Calandrino FS, et al.: Improved outcome based on fluid management in critically ill patients requiring pulmonary catheter catheterization. Am Rev Respir Dis 1992, 145:990-998.
39. Joynt GM, Antonio GE, Lam P, et al.: Thin-section computed tomography abnormalities in patients with late adult respiratory distress syndrome (ARDS) caused by severe acute respiratory syndrome (SARS). Radiology 2004, 230:339-346.
40. Pittet D: Improving compliance with hand hygiene in hospitals. Infect Control Hosp Epidemiol 2000, 21:381-386.
41. Herridge MS, Cheung AM, Tansey CM, et al.: One-year outcomes in survivors of the ARDS. N Engl J Med 2003, 348:683-693.
42. Severe acute respiratory syndrome (SARS). Centers for Disease Control and Prevention, 2003. http://www.cdc.gov/nci-dod/sars. Accessed January 8, 2004.
43. World Health Organization: Hospital infection control guidance for severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/infectioncontrol/en. Accessed April 11, 2003.
44. Gomersall CD, Joynt GM: Severe acute respiratory syndrome (SARS). http://www.aic.cuhk.hk/web8/sars.htm. Accessed January 8, 2004.
45. Li TS, Buckley TA, Yap FH, et al.: Severe acute respiratory syndrome (SARS): infection control. Lancet 2003, 361:1386.
46. Drosten C, Gunther S, Preiser W, et al.: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003, 348:1967-1976.
47. Tomlinson B, Cockram C: SARS: experience at Prince of Wales Hospital, Hong Kong. Lancet 2003, 361:1486-1487.
48. Hong Kong Department of Health Report. Main findings of an investigation into the outbreak of severe acute respiratory syndrome at Amoy Gardens. http://www.info.gov.hk/dh/ap.htm. Accessed April 19, 2003.
49. Garner JS, Hospital Infection Control Practices Advisory Committee: Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996, 17:53-80, and Am J Infect Control 1996, 24:24-52.
50. Respiratory Protection Program. US Department of Labor. Occupational Safety and Health Administration. http://www.osha.gov/SLTC/etools/respiratory. Accessed January 8, 2004.
51. Hospital infection control guidance for severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/infection-control/en. Accessed April 11, 2003.